当前位置:首页 - 行情中心 - 派林生物(000403) - 财务分析 - 现金流量表

派林生物

(000403)

  

流通市值:97.27亿  总市值:98.27亿
流通股本:9.41亿   总股本:9.50亿

现金流量表

报告期2026-06-302026-03-312025-12-312025-09-30
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金1,104,422,278.18474,645,161.972,126,498,241.351,638,382,857.13
  收到的税费返还8,823,835.24-5,367,630.65-
  收到其他与经营活动有关的现金21,389,432.495,452,119.6633,882,533.9637,527,087.58
  经营活动现金流入小计1,134,635,545.91480,097,281.632,165,748,405.961,675,909,944.71
  购买商品、接受劳务支付的现金674,105,472.67374,194,999.431,439,516,459.31,078,534,154.42
  支付给职工以及为职工支付的现金205,111,123.6113,372,082.92354,237,291.72274,556,311.9
  支付的各项税费144,682,989.9786,816,287.42223,234,516.9165,157,908.47
  支付其他与经营活动有关的现金194,607,718.1177,565,467364,750,751.3254,148,415.01
  经营活动现金流出小计1,218,507,304.35651,948,836.772,381,739,019.221,772,396,789.8
  经营活动产生的现金流量净额-83,871,758.44-171,851,555.14-215,990,613.26-96,486,845.09
二、投资活动产生的现金流量:
  收回投资收到的现金450,026,867.96300,000,0001,480,000,000880,000,000
  取得投资收益收到的现金7,918,743.672,723,573.6117,593,226.8614,126,885.63
  处置固定资产、无形资产和其他长期资产收回的现金净额31,686.31,911.5493,018.55211,783.81
  收到的其他与投资活动有关的现金23,852,054.7913,315,068.4953,999,999.9840,536,986.29
  投资活动现金流入小计481,829,352.72316,040,553.61,552,086,245.39934,875,655.73
  购建固定资产、无形资产和其他长期资产支付的现金69,982,470.3733,776,304.86333,403,421.77250,229,572.61
  投资支付的现金460,000,000310,000,0001,450,000,0001,260,050,000
  支付其他与投资活动有关的现金150,000,000100,000,000--
  投资活动现金流出小计679,982,470.37443,776,304.861,783,403,421.771,510,279,572.61
  投资活动产生的现金流量净额-198,153,117.65-127,735,751.26-231,317,176.38-575,403,916.88
三、筹资活动产生的现金流量:
  吸收投资收到的现金--100,00050,000
  其中:子公司吸收少数股东投资收到的现金--100,00050,000
  取得借款收到的现金658,102,000103,500,000771,207,747.13534,318,741.72
  筹资活动现金流入小计658,102,000103,500,000771,307,747.13534,368,741.72
  偿还债务支付的现金268,228,790.87133,133,164.62595,309,148.65337,713,522.4
  分配股利、利润或偿付利息支付的现金10,772,746.454,858,839.98273,799,760.63268,908,749.44
  支付其他与筹资活动有关的现金118,500,949.23517,811.015,704,350.383,375,393.33
  筹资活动现金流出小计397,502,486.55138,509,815.61874,813,259.66609,997,665.17
  筹资活动产生的现金流量净额260,599,513.45-35,009,815.61-103,505,512.53-75,628,923.45
四、汇率变动对现金及现金等价物的影响-62,263.45-31,771.3849,364.89-23,583.88
五、现金及现金等价物净增加额-21,487,626.09-334,628,893.39-550,763,937.28-747,543,269.3
  加:期初现金及现金等价物余额769,596,617.33769,596,617.331,320,360,554.611,320,360,554.61
  期末现金及现金等价物余额748,108,991.24434,967,723.94769,596,617.33572,817,285.31
补充资料:
  净利润84,973,590.59-419,535,951.9-
  资产减值准备365,386.04-100,052,963.37-
  固定资产和投资性房地产折旧66,071,438.48-116,414,975.28-
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧66,071,438.48-116,386,495.44-
    投资性房地产折旧--28,479.84-
  无形资产摊销11,211,647.93-20,591,534.24-
  长期待摊费用摊销10,291,730.72-9,271,024.41-
  处置固定资产、无形资产和其他长期资产的损失135,615.12--756,002.27-
  固定资产报废损失372,752.16-754,255.1-
  公允价值变动损失180,180.4--4,296,114.07-
  财务费用-11,041,273.76--32,814,439.01-
  投资损失-3,538,606.1--8,953,532.37-
  递延所得税-783,989.13-2,593,122.97-
  其中:递延所得税资产减少1,596,345.38-2,843,705.76-
    递延所得税负债增加-2,380,334.51--250,582.79-
  存货的减少-337,560,871.97--332,406,933.51-
  经营性应收项目的减少131,101,047.96--472,671,425.47-
  经营性应付项目的增加-37,014,482.76--47,788,798.62-
  现金的期末余额748,108,991.24-769,596,617.33-
  减:现金的期初余额769,596,617.33-1,320,360,554.61-
  现金及现金等价物的净增加额-21,487,626.09--550,763,937.28-
公告日期2026-08-242026-04-292026-04-292025-10-29
审计意见(境内)标准无保留意见
TOP↑